Cargando…
HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
BACKGROUND: The discovery of diketoacid-containing derivatives as inhibitors of HIV-1 Integrase (IN) (IN inhibitors, IINs) has played a major role in validating this enzyme as an important target for antiretroviral therapy. Since the in vivo efficacy depends on access of these drugs to intracellular...
Autores principales: | Cianfriglia, Maurizio, Dupuis, Maria Luisa, Molinari, Agnese, Verdoliva, Antonio, Costi, Roberta, Galluzzo, Clementina Maria, Andreotti, Mauro, Cara, Andrea, Di Santo, Roberto, Palmisano, Lucia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1828167/ https://www.ncbi.nlm.nih.gov/pubmed/17343726 http://dx.doi.org/10.1186/1742-4690-4-17 |
Ejemplares similares
-
Raltegravir does not revert efflux activity of MDR1-P-glycoprotein in human MDR cells
por: Dupuis, Maria Luisa, et al.
Publicado: (2013) -
Novel Quinolinonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, and Biological Activities
por: Di Santo, Roberto, et al.
Publicado: (2008) -
Evaluation the interaction of ABC multidrug transporter MDR1 with thymoquinone: substrate or inhibitor?
por: Keyvani, Vahideh, et al.
Publicado: (2020) -
Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo
por: Wang, Gangyang, et al.
Publicado: (2022) -
HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein
por: Chen, Jianfang, et al.
Publicado: (2014)